Brendan Delaney serves as Executive at Aadi Bioscience, Inc., where they oversee executive responsibilities. Since joining the company, Brendan Delaney has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 26, 2022 involved receiving (via award) 20,000 shares valued at $250.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 26, 2022 | AADI | $250.0K | Award | 20,000 | $12.50 | Discretionary |
Brendan Delaney currently holds 20,000 shares of Aadi Bioscience, Inc. (AADI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brendan Delaney has been a net neutral trader of AADI stock. They have purchased $0 and sold $0 worth of shares.
Brendan Delaney's most recent insider trade was on Sep 26, 2022, when they sold 20,000 shares at $12.50 per share.
Get notified when new Form 4 filings are submitted